Jan 27, 2025 | Federal Trade Commission (FTC), MedBen Rx, News, Pharmacy Benefits Manager (PBM), Rx Costs, Specialty Drugs, Spread Pricing
Through specialty generic drug markups, three major pharmacy benefit managers (PBMs) earned a collective $7.3 billion above estimated acquisition costs over a five-year period, according to an interim report released by the Federal Trade Commission (FTC)....
Oct 28, 2024 | Federal Trade Commission (FTC), Pharmacies, Rebates, Spread Pricing
KFF Health News reports on the disparity between pharmacy benefit manager (PBM) payments to large pharmacy chains compared to small drugstores: “[An American Pharmacy Cooperative] analysis early this year showed chains were paid well beyond the family business...
Jul 23, 2024 | Federal Trade Commission (FTC), Formularies, News, Pharmacy Benefits Manager (PBM)
In an interim report released on July 9, the Federal Trade Commission charges major pharmacy benefit managers of engaging in business practices designed to benefit their own bottom lines at the expense of clients. The FTC report, subtitled “The Powerful...
